(1) The following categories of drugs are acceptable for dispensing or distribution under the program:
(a) a cancer drug that is in its original, unopened, sealed, and tamper-evident packaging;
(b) a cancer drug packaged in single unit doses if the outside packaging is opened, but the single unit dose packaging is unopened;
(c) a cancer drug that does not require refrigeration, freezing, or other special temperature requirements beyond controlled room temperature; and
(d) an injectable cancer drug if it does not have temperature requirements other than controlled room temperature.
(2) Any cancer drug donated to the program must have at least six months remaining before its expiration date occurs.
(3) Any cancer drug donated to the program cannot be used past its expiration date.